FDA probes Intuitive Surgical on complication rates
March 1, 2013 by Brad Perriello
The FDA surveys doctors on complications experienced using Intuitive Surgical's da Vinci surgical robot, sending shares down on Wall Street.
The FDA is looking into complication rates for surgeries using Intuitive Surgical's (NSDQ:ISRG) da Vinci surgical robot, sending a survey to doctors who use the device.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
Navigation
NEWS
Biosensors International wins CE Mark for latest line of drug-eluting stents
Biosensors International lands European approval for its BioMatrix NeoFlex drug-eluting stent.
ViewRay closes in on $17.4M round
Medical device company ViewRay announces a $17.4 million funding round, offering equity and Series D-...
Diabetes: Abbott's glucose monitor software glitch gets FDA's highest-risk recall
The FDA slaps its highest-risk classification on Abbott Labs' FreeStyle InsuLinx blood glucose meter...
Weight loss: GI Dynamics' U.S. clinical trial taxes its coffers
Weight-loss devices maker GI Dynamics tells investors today that the company may seek new funding as...
Medtronic touts European win for Export Advance aspiration catheter
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent...
